DCM
TNYA icon

DAFNA Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

DAFNA Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+300,000
New +$228K 0.04% 84
2025
Q2 		– Sell
-47,319
Closed -$27K – 83
2025
Q1 		$27K Buy
+47,319
New +$46.7K 0.01% 83

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DAFNA Capital Management's TNYA Position: Q2 2026 in Review

DAFNA Capital Management opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 300,000 shares worth $222K. The stake represents 0.04% of the portfolio and ranks #84 among its holdings. This is a return to the name: DAFNA Capital Management previously reported a position in TNYA as recently as Q1 2025.

DAFNA Capital Management first reported a position in TNYA in Q1 2025 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • DAFNA Capital Management held 300,000 shares of Tenaya Therapeutics worth $222K as of Q2 2026.
  • Tenaya Therapeutics was a new DAFNA Capital Management position in Q2 2026.
  • Tenaya Therapeutics made up 0.04% of DAFNA Capital Management's portfolio in Q2 2026, its #84 holding.
  • DAFNA Capital Management first reported a position in Tenaya Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on DAFNA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.